Proteasome Inhibitors Evoke Latent Tumor Suppression Programs in Pro-B MLL Leukemias through MLL-AF4-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Proteasome Inhibitors Evoke Latent Tumor Suppression Programs in Pro-B MLL Leukemias through MLL-AF4

Published:2014-04 Issue:4 Volume:25 Page:530-542
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Liu Han,Westergard Todd D.,Cashen Amanda,Piwnica-Worms David R.,Kunkle Lori,Vij Ravi,Pham Can G.,DiPersio John,Cheng Emily H.,Hsieh James J.

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference62 articles.

1. The proteasome: a suitable antineoplastic target;Adams;Nat. Rev. Cancer,2004

2. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins;Ayton;Oncogene,2001

3. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity;Barretina;Nature,2012

4. High-risk childhood acute lymphoblastic leukemia;Bhojwani;Clin. Lymphoma Myeloma,2009

5. Transcriptional control of early B cell development;Busslinger;Annu. Rev. Immunol.,2004

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interplay between proteasome inhibitors and NF-κB pathway in leukemia and lymphoma: a comprehensive review on challenges ahead of proteasome inhibitors;Cell Communication and Signaling;2024-02-08

2. Bortezomib Is Effective in the Treatment of T Lymphoblastic Leukaemia by Inducing DNA Damage, WEE1 Downregulation, and Mitotic Catastrophe;International Journal of Molecular Sciences;2023-09-27

3. Proteasome inhibition targets the KMT2A transcriptional complex in acute lymphoblastic leukemia;Nature Communications;2023-02-13

4. Functional, structural, and molecular characterizations of the leukemogenic driver MEF2D-HNRNPUL1 fusion;Blood;2022-09-22

5. Menin-MLL Inhibitor MI-503 Blocks Menin Nuclear Export and Suppresses Hypergastrinemia;2022-05-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3